{"classes":[{"categories":[{"measurements":[{"comment":"2.07, 7.16 (Individual values reported as there were only two participants)","groupId":"OG000","spread":"NA","value":"NA"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"}],"units":"Participants"}],"description":"Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3435151.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Participants received 10 mg dose of LY3435151 via intravenous (IV) as an IV push or IV bolus infusion.","id":"OG000","title":"10 mg LY3435151"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"All randomized participants who received at least one dose of study drug and had evaluable PK data.","reportingStatus":"POSTED","timeFrame":"Cycle 1 Day 1 (C1D1) (Predose, 1, 3 hour (hr), C1D2 (24 hr), C1D4 (72hr), C1D8 (168hr), C1D15 (336hr)","title":"Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3435151","type":"SECONDARY","unitOfMeasure":"microgram per milliliter (µg/mL)"}